RESEARCH
Postoperative Use of Fascia Iliaca Compartment Block for Patients with Hip Fractures: A Systematic Review of Randomized Controlled Trials .
In the search for effective and safer alternatives to opioids for managing postoperative pain in hip fracture patients, fascia iliaca compartment block (FICB) has emerged as a promising candidate. RCT evidence evaluating the postoperative use of FICB for hip fracture patients had six trials assess pain at 4, 12, 24, and 48 hours, opioid consumption at 24 hours, and safety outcomes including nausea/vomiting, hypotension, and pruritus. Across all measures, FICB showed no superiority or inferiority compared with active controls. Evidence certainty was very low due to risk of bias, imprecision, and heterogeneity in interventions and comparators. While current findings suggest no clear benefit, higher-quality RCTs with larger samples and standardized protocols are needed to determine the true efficacy and safety of postoperative FICB.
Already have an account? Log in
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
